1. Home
  2. NVCR vs SGHC Comparison

NVCR vs SGHC Comparison

Compare NVCR & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • SGHC
  • Stock Information
  • Founded
  • NVCR 2000
  • SGHC 2020
  • Country
  • NVCR Jersey
  • SGHC Guernsey
  • Employees
  • NVCR N/A
  • SGHC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • SGHC Services-Misc. Amusement & Recreation
  • Sector
  • NVCR Health Care
  • SGHC Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • SGHC Nasdaq
  • Market Cap
  • NVCR 1.8B
  • SGHC 1.8B
  • IPO Year
  • NVCR 2015
  • SGHC N/A
  • Fundamental
  • Price
  • NVCR $17.49
  • SGHC $4.17
  • Analyst Decision
  • NVCR Buy
  • SGHC Strong Buy
  • Analyst Count
  • NVCR 5
  • SGHC 2
  • Target Price
  • NVCR $26.60
  • SGHC $5.50
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • SGHC 325.4K
  • Earning Date
  • NVCR 10-30-2024
  • SGHC 11-06-2024
  • Dividend Yield
  • NVCR N/A
  • SGHC N/A
  • EPS Growth
  • NVCR N/A
  • SGHC N/A
  • EPS
  • NVCR N/A
  • SGHC 0.01
  • Revenue
  • NVCR $549,964,000.00
  • SGHC $1,618,776,385.00
  • Revenue This Year
  • NVCR $16.23
  • SGHC $11.34
  • Revenue Next Year
  • NVCR $6.09
  • SGHC $8.57
  • P/E Ratio
  • NVCR N/A
  • SGHC $351.26
  • Revenue Growth
  • NVCR 8.33
  • SGHC 11.40
  • 52 Week Low
  • NVCR $10.87
  • SGHC $2.63
  • 52 Week High
  • NVCR $24.74
  • SGHC $4.25
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • SGHC 72.35
  • Support Level
  • NVCR $15.61
  • SGHC $4.10
  • Resistance Level
  • NVCR $17.31
  • SGHC $4.25
  • Average True Range (ATR)
  • NVCR 1.29
  • SGHC 0.10
  • MACD
  • NVCR 0.05
  • SGHC -0.01
  • Stochastic Oscillator
  • NVCR 11.59
  • SGHC 82.76

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.

Share on Social Networks: